Selarsdi 51759-0708
Generic: Ustekinumab-Aekn
Product NDC
51759-0708- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 12, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA761343
Need to source Selarsdi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ustekinumab-Aekn | 130 mg/26mL |
Drug Class
Interleukin-12 Antagonist [EPC]Interleukin-12 Antagonists [MoA]Interleukin-23 Antagonist [EPC]
Packaging Options(1)
1 VIAL, GLASS in 1 CARTON (51759-708-13) / 26 mL in 1 VIAL, GLASS